Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Neoadjuvant Trial in Breast Cancer With Combination of ABI-007 (Abraxane) and GW572016 (Lapatinib)

NCT00331630 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT00331630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00331630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Neoadjuvant Trial in Breast Cancer With Combination of ABI-007 (Abraxane) and GW572016 (Lapatinib)
Lead sponsor
Northwestern University
Phase
Phase 1
Overall status
Completed
Start date
May 4, 2006
Completion date
August 5, 2010
Enrollment
30 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer